Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 2Neurotoxicity Syndromes 1Neoplasm Metastasis 1Central Nervous System Carcinoma 1

Interventions

Paclitaxel 4Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Mental Status and Dementia Tests 2Cisplatin 2Amifostine 2Vincristine 1Temozolomide 1Rituximab 1Procarbazine 1Methotrexate 1Memantine 1Magnetic Resonance Spectroscopy 1Diffusion Tensor Imaging 1Cytarabine 1Carboplatin 1Brachytherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neurotoxicity Syndromes × Memantine × Clear all
NCT00566852 2017-08-21

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Radiation Therapy Oncology Group

Phase 3 Completed
554 enrolled 12 charts
CNS

Brain Neoplasms, Neoplasm Metastasis, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡